Form 4 holding
Director
Inozyme Pharma, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 28,000
- Estimated value
- Report date
- 18 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount